0001742362-19-000003.txt : 20190924
0001742362-19-000003.hdr.sgml : 20190924
20190924165627
ACCESSION NUMBER: 0001742362-19-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190924
DATE AS OF CHANGE: 20190924
EFFECTIVENESS DATE: 20190924
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: iKOR Labs Inc.
CENTRAL INDEX KEY: 0001742362
IRS NUMBER: 814255494
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-349536
FILM NUMBER: 191111353
BUSINESS ADDRESS:
STREET 1: 2840 WILDERNESS PLACE
STREET 2: SUITE G
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3035066476
MAIL ADDRESS:
STREET 1: 2840 WILDERNESS PLACE
STREET 2: SUITE G
CITY: BOULDER
STATE: CO
ZIP: 80301
D
1
primary_doc.xml
X0708
D
LIVE
0001742362
iKOR Labs Inc.
2840 WILDERNESS PLACE
SUITE G
BOULDER
CO
COLORADO
80301
3035066476
COLORADO
None
None
Corporation
true
2016
Mark
Fleming
9227 E Lincoln Ave, 200-406
Lone Tree
CO
COLORADO
80124
Executive Officer
Director
Craig
Martin
Sweeney
2840 Wilderness Place
Suite G
Boulder
CO
COLORADO
80301
Executive Officer
Other Health Care
Decline to Disclose
- 06b
false
2019-09-09
false
true
false
0
300000
50000
250000
false
2
0
0
0
true
If revenues are not sufficient to pay the salaries of Company employees (including directors/officers), offering proceeds reserved for working capital will be used to supplement the payment of such amounts.
false
iKOR Labs Inc.
MARK FLEMING
Mark Fleming
CEO
2019-09-24